The cholesterol metabolite 25-hydroxycholesterol suppresses porcine deltacoronavirus via lipophagy inhibition and mTORC1 modulation
View abstract on PubMed
Summary
This summary is machine-generated.25-Hydroxycholesterol (25HC) enhances antiviral defenses by promoting lipid droplet accumulation and inhibiting lipophagy, thereby controlling porcine deltacoronavirus (PDCoV) replication and improving piglet health.
Area Of Science
- Virology
- Cell Biology
- Biochemistry
Background
- 25-Hydroxycholesterol (25HC) exhibits antiviral properties, but its role in regulating lipid metabolism and antiviral defense against porcine deltacoronavirus (PDCoV) remains unclear.
- Cholesterol homeostasis and lipid droplet (LD) dynamics are critical for viral replication, yet the interplay with 25HC in PDCoV infection requires elucidation.
Purpose Of The Study
- To investigate the antiviral mechanism of 25HC against PDCoV in vitro and in vivo.
- To explore how 25HC influences lipid metabolism, specifically LD accumulation and lipophagy, in the context of PDCoV infection.
- To determine the effect of 25HC on PDCoV-infected piglets' clinical outcomes and intestinal health.
Main Methods
- Treatment of PDCoV-infected LLC-PK1 cells and piglets with 25HC.
- Measurement of free cholesterol (FC) and triglyceride (TG) levels.
- Assessment of LD accumulation, lipophagy, and lysosomal protein expression.
- Analysis of transcription factor EB (TFEB) and mTORC1 signaling pathway activity.
- Evaluation of clinical symptoms and intestinal injury in infected piglets.
Main Results
- 25HC treatment reduced FC levels and increased TG levels in PDCoV-infected cells and piglets.
- 25HC promoted LD accumulation by decreasing protein expression related to lipophagy and lysosomes.
- 25HC inhibited TFEB nuclear translocation and mTORC1 activity, consequently hindering lipophagy and PDCoV replication.
- 25HC administration alleviated clinical symptoms and intestinal damage in PDCoV-infected piglets.
Conclusions
- 25HC exerts antiviral effects against PDCoV by modulating lipid metabolism and promoting LD accumulation.
- The antiviral mechanism involves the inhibition of lipophagy via TFEB and mTORC1 signaling pathways.
- 25HC demonstrates therapeutic potential for PDCoV infection by improving host defense and reducing viral pathogenesis.

